InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Decicco Carl, Directeur Scientifique. Insider active across 1 company, notably Foghorn Therapeutics Inc.. Cumulatively, 1 reports have been published. History available since 9 December 2021. The latest transaction was filed on 9 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
DECICCO CARL is the Chief Scientific Officer at Foghorn Therapeutics Inc. In this role, he oversees research and development initiatives, ensuring innovation and advancement of scientific projects. Carl brings expertise in the biotechnology field, contributing to the evolution of gene therapies.